Next Generation Cancer Diagnostics Market 2027 By Technology, Application, Cancer Type, Function and Geography | The Insight Partners

Next Generation Cancer Diagnostics Market to 2027 - Global Analysis and Forecasts By Technology (qPCR and Multiplexing, Benchtop Sequencers, Lab-on-a-chip, Next Generation Sequencing, Protein Microarrays, DNA Microarrays, Other Technologies); Application (Biomarker Development, Proteomic Analysis, CTC Analysis, Genetic Analysis, Epigenetic Analysis); Cancer Type (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Others); Function (Cancer Screening, Therapeutic Monitoring, Prognosis Diagnostics, Risk Analysis, Companion Diagnostics) and Geography

Report Code: TIPRE00006920 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

The next generation cancer diagnostics technologies are aiding in early cancer diagnostics and prevention. Researchers are continuously taking efforts in developing new diagnostic tools for cancer as well as advancing the existing ones. Many of the market players are collaborating for the development of new cancer biomarkers and assays, thus favoring market growth.

MARKET DYNAMICS

The next generation cancer diagnostics market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of cancer cases, continuous technological advancements in cancer diagnostics, and rising need for efficient cancer screening tests. Furthermore, high research and development activities for development of new cancer diagnostic products is likely to pose growth opportunities for the next generation cancer diagnostics market to grow.

MARKET SCOPE

The "Global Next Generation Cancer Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of next generation cancer diagnostics market with detailed market segmentation by technology, application, cancer type and function and geography. The global next generation cancer diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading next generation cancer diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global next generation cancer diagnostics market is segmented on the basis of technology, application, cancer type and function. Based on product the market is segmented into qPCR and multiplexing, benchtop sequencers, lab-on-a-chip, next generation sequencing, protein microarrays, DNA microarrays, other technologies. Based on application the market is segmented into biomarker development, proteomic analysis, CTC analysis, genetic analysis, and epigenetic analysis. Based on cancer type the market is segmented into lung cancer, colorectal cancer, breast cancer, prostate cancer, and others. The function segment is segmented into cancer screening, therapeutic monitoring, prognosis diagnostics, risk analysis, and companion diagnostics.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global next generation cancer diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The next generation cancer diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting next generation cancer diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the next generation cancer diagnostics market in these regions.

MARKET PLAYERS


The reports cover key developments in the next generation cancer diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from next generation cancer diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for next generation cancer diagnostics market in the global market. Below mentioned is the list of few companies engaged in the next generation cancer diagnostics market.

The report also includes the profiles of next generation cancer diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Agilent Technologies, Inc.
  •  Biospherex LLC
  •  Cepheid
  •  F. Hoffmann-La Roche Ltd
  •  General Electric Co.
  •  Lunaphore Technologies S.A.
  •  QIAGEN N.V
  •  Thermo Fisher Scientific Inc.
  •  Abbott
  •  Koninklijke Philips N.V.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Next Generation Cancer Diagnostics Market - By Technology
1.3.2 Next Generation Cancer Diagnostics Market - By Application
1.3.3 Next Generation Cancer Diagnostics Market - By Cancer Type
1.3.4 Next Generation Cancer Diagnostics Market - By Function
1.3.5 Next Generation Cancer Diagnostics Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. NEXT GENERATION CANCER DIAGNOSTICS MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. NEXT GENERATION CANCER DIAGNOSTICS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NEXT GENERATION CANCER DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS

6.1. NEXT GENERATION CANCER DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. NEXT GENERATION CANCER DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. NEXT GENERATION CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY

7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. QPCR AND MULTIPLEXING
7.3.1. Overview
7.3.2. qPCR and Multiplexing Market Forecast and Analysis
7.4. BENCHTOP SEQUENCERS
7.4.1. Overview
7.4.2. Benchtop Sequencers Market Forecast and Analysis
7.5. LAB-ON-A-CHIP
7.5.1. Overview
7.5.2. Lab-on-a-chip Market Forecast and Analysis
7.6. NEXT GENERATION SEQUENCING
7.6.1. Overview
7.6.2. Next Generation Sequencing Market Forecast and Analysis
7.7. PROTEIN MICROARRAYS
7.7.1. Overview
7.7.2. Protein Microarrays Market Forecast and Analysis
7.8. DNA MICROARRAYS
7.8.1. Overview
7.8.2. DNA Microarrays Market Forecast and Analysis
7.9. OTHER TECHNOLOGIES
7.9.1. Overview
7.9.2. Other Technologies Market Forecast and Analysis

8. NEXT GENERATION CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BIOMARKER DEVELOPMENT
8.3.1. Overview
8.3.2. Biomarker Development Market Forecast and Analysis
8.4. PROTEOMIC ANALYSIS
8.4.1. Overview
8.4.2. Proteomic Analysis Market Forecast and Analysis
8.5. CTC ANALYSIS
8.5.1. Overview
8.5.2. CTC Analysis Market Forecast and Analysis
8.6. GENETIC ANALYSIS
8.6.1. Overview
8.6.2. Genetic Analysis Market Forecast and Analysis
8.7. EPIGENETIC ANALYSIS
8.7.1. Overview
8.7.2. Epigenetic Analysis Market Forecast and Analysis

9. NEXT GENERATION CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - CANCER TYPE

9.1. OVERVIEW
9.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
9.3. LUNG CANCER
9.3.1. Overview
9.3.2. Lung Cancer Market Forecast and Analysis
9.4. COLORECTAL CANCER
9.4.1. Overview
9.4.2. Colorectal Cancer Market Forecast and Analysis
9.5. BREAST CANCER
9.5.1. Overview
9.5.2. Breast Cancer Market Forecast and Analysis
9.6. PROSTATE CANCER
9.6.1. Overview
9.6.2. Prostate Cancer Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis

10. NEXT GENERATION CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - FUNCTION

10.1. OVERVIEW
10.2. FUNCTION MARKET FORECASTS AND ANALYSIS
10.3. CANCER SCREENING
10.3.1. Overview
10.3.2. Cancer Screening Market Forecast and Analysis
10.4. THERAPEUTIC MONITORING
10.4.1. Overview
10.4.2. Therapeutic Monitoring Market Forecast and Analysis
10.5. PROGNOSIS DIAGNOSTICS
10.5.1. Overview
10.5.2. Prognosis Diagnostics Market Forecast and Analysis
10.6. RISK ANALYSIS
10.6.1. Overview
10.6.2. Risk Analysis Market Forecast and Analysis
10.7. COMPANION DIAGNOSTICS
10.7.1. Overview
10.7.2. Companion Diagnostics Market Forecast and Analysis

11. NEXT GENERATION CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

11.1. NORTH AMERICA
11.1.1 North America Next Generation Cancer Diagnostics Market Overview
11.1.2 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.1.3 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.1.4 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.1.5 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.1.6 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.1.7 North America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Next Generation Cancer Diagnostics Market
11.1.7.1.1 United States Next Generation Cancer Diagnostics Market by Technology
11.1.7.1.2 United States Next Generation Cancer Diagnostics Market by Application
11.1.7.1.3 United States Next Generation Cancer Diagnostics Market by Cancer Type
11.1.7.1.4 United States Next Generation Cancer Diagnostics Market by Function
11.1.7.2 Canada Next Generation Cancer Diagnostics Market
11.1.7.2.1 Canada Next Generation Cancer Diagnostics Market by Technology
11.1.7.2.2 Canada Next Generation Cancer Diagnostics Market by Application
11.1.7.2.3 Canada Next Generation Cancer Diagnostics Market by Cancer Type
11.1.7.2.4 Canada Next Generation Cancer Diagnostics Market by Function
11.1.7.3 Mexico Next Generation Cancer Diagnostics Market
11.1.7.3.1 Mexico Next Generation Cancer Diagnostics Market by Technology
11.1.7.3.2 Mexico Next Generation Cancer Diagnostics Market by Application
11.1.7.3.3 Mexico Next Generation Cancer Diagnostics Market by Cancer Type
11.1.7.3.4 Mexico Next Generation Cancer Diagnostics Market by Function
11.2. EUROPE
11.2.1 Europe Next Generation Cancer Diagnostics Market Overview
11.2.2 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.2.3 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.2.4 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.2.5 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.2.6 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.2.7 Europe Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Next Generation Cancer Diagnostics Market
11.2.7.1.1 Germany Next Generation Cancer Diagnostics Market by Technology
11.2.7.1.2 Germany Next Generation Cancer Diagnostics Market by Application
11.2.7.1.3 Germany Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.1.4 Germany Next Generation Cancer Diagnostics Market by Function
11.2.7.2 France Next Generation Cancer Diagnostics Market
11.2.7.2.1 France Next Generation Cancer Diagnostics Market by Technology
11.2.7.2.2 France Next Generation Cancer Diagnostics Market by Application
11.2.7.2.3 France Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.2.4 France Next Generation Cancer Diagnostics Market by Function
11.2.7.3 Italy Next Generation Cancer Diagnostics Market
11.2.7.3.1 Italy Next Generation Cancer Diagnostics Market by Technology
11.2.7.3.2 Italy Next Generation Cancer Diagnostics Market by Application
11.2.7.3.3 Italy Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.3.4 Italy Next Generation Cancer Diagnostics Market by Function
11.2.7.4 Spain Next Generation Cancer Diagnostics Market
11.2.7.4.1 Spain Next Generation Cancer Diagnostics Market by Technology
11.2.7.4.2 Spain Next Generation Cancer Diagnostics Market by Application
11.2.7.4.3 Spain Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.4.4 Spain Next Generation Cancer Diagnostics Market by Function
11.2.7.5 United Kingdom Next Generation Cancer Diagnostics Market
11.2.7.5.1 United Kingdom Next Generation Cancer Diagnostics Market by Technology
11.2.7.5.2 United Kingdom Next Generation Cancer Diagnostics Market by Application
11.2.7.5.3 United Kingdom Next Generation Cancer Diagnostics Market by Cancer Type
11.2.7.5.4 United Kingdom Next Generation Cancer Diagnostics Market by Function
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Next Generation Cancer Diagnostics Market Overview
11.3.2 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.3.3 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.3.4 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.3.6 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.3.7 Asia-Pacific Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Next Generation Cancer Diagnostics Market
11.3.7.1.1 Australia Next Generation Cancer Diagnostics Market by Technology
11.3.7.1.2 Australia Next Generation Cancer Diagnostics Market by Application
11.3.7.1.3 Australia Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.1.4 Australia Next Generation Cancer Diagnostics Market by Function
11.3.7.2 China Next Generation Cancer Diagnostics Market
11.3.7.2.1 China Next Generation Cancer Diagnostics Market by Technology
11.3.7.2.2 China Next Generation Cancer Diagnostics Market by Application
11.3.7.2.3 China Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.2.4 China Next Generation Cancer Diagnostics Market by Function
11.3.7.3 India Next Generation Cancer Diagnostics Market
11.3.7.3.1 India Next Generation Cancer Diagnostics Market by Technology
11.3.7.3.2 India Next Generation Cancer Diagnostics Market by Application
11.3.7.3.3 India Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.3.4 India Next Generation Cancer Diagnostics Market by Function
11.3.7.4 Japan Next Generation Cancer Diagnostics Market
11.3.7.4.1 Japan Next Generation Cancer Diagnostics Market by Technology
11.3.7.4.2 Japan Next Generation Cancer Diagnostics Market by Application
11.3.7.4.3 Japan Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.4.4 Japan Next Generation Cancer Diagnostics Market by Function
11.3.7.5 South Korea Next Generation Cancer Diagnostics Market
11.3.7.5.1 South Korea Next Generation Cancer Diagnostics Market by Technology
11.3.7.5.2 South Korea Next Generation Cancer Diagnostics Market by Application
11.3.7.5.3 South Korea Next Generation Cancer Diagnostics Market by Cancer Type
11.3.7.5.4 South Korea Next Generation Cancer Diagnostics Market by Function
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Next Generation Cancer Diagnostics Market Overview
11.4.2 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.4.3 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.4.4 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.4.6 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.4.7 Middle East and Africa Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Next Generation Cancer Diagnostics Market
11.4.7.1.1 South Africa Next Generation Cancer Diagnostics Market by Technology
11.4.7.1.2 South Africa Next Generation Cancer Diagnostics Market by Application
11.4.7.1.3 South Africa Next Generation Cancer Diagnostics Market by Cancer Type
11.4.7.1.4 South Africa Next Generation Cancer Diagnostics Market by Function
11.4.7.2 Saudi Arabia Next Generation Cancer Diagnostics Market
11.4.7.2.1 Saudi Arabia Next Generation Cancer Diagnostics Market by Technology
11.4.7.2.2 Saudi Arabia Next Generation Cancer Diagnostics Market by Application
11.4.7.2.3 Saudi Arabia Next Generation Cancer Diagnostics Market by Cancer Type
11.4.7.2.4 Saudi Arabia Next Generation Cancer Diagnostics Market by Function
11.4.7.3 U.A.E Next Generation Cancer Diagnostics Market
11.4.7.3.1 U.A.E Next Generation Cancer Diagnostics Market by Technology
11.4.7.3.2 U.A.E Next Generation Cancer Diagnostics Market by Application
11.4.7.3.3 U.A.E Next Generation Cancer Diagnostics Market by Cancer Type
11.4.7.3.4 U.A.E Next Generation Cancer Diagnostics Market by Function
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Next Generation Cancer Diagnostics Market Overview
11.5.2 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis
11.5.3 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Technology
11.5.4 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Application
11.5.5 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
11.5.6 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Function
11.5.7 South and Central America Next Generation Cancer Diagnostics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Next Generation Cancer Diagnostics Market
11.5.7.1.1 Brazil Next Generation Cancer Diagnostics Market by Technology
11.5.7.1.2 Brazil Next Generation Cancer Diagnostics Market by Application
11.5.7.1.3 Brazil Next Generation Cancer Diagnostics Market by Cancer Type
11.5.7.1.4 Brazil Next Generation Cancer Diagnostics Market by Function
11.5.7.2 Argentina Next Generation Cancer Diagnostics Market
11.5.7.2.1 Argentina Next Generation Cancer Diagnostics Market by Technology
11.5.7.2.2 Argentina Next Generation Cancer Diagnostics Market by Application
11.5.7.2.3 Argentina Next Generation Cancer Diagnostics Market by Cancer Type
11.5.7.2.4 Argentina Next Generation Cancer Diagnostics Market by Function

12. INDUSTRY LANDSCAPE

12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. NEXT GENERATION CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES

13.1. AGILENT TECHNOLOGIES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BIOSPHEREX LLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. CEPHEID
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. F. HOFFMANN-LA ROCHE LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GENERAL ELECTRIC CO.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. LUNAPHORE TECHNOLOGIES S.A.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. QIAGEN N.V.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. THERMO FISHER SCIENTIFIC INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ABBOTT
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. KONINKLIJKE PHILIPS N.V.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX

14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Koninklijke Philips N.V.
2. Agilent Technologies, Inc.
3. Biospherex LLC
4. Cepheid
5. F. Hoffmann-La Roche Ltd
6. General Electric Co.
7. Lunaphore Technologies S.A.
8. QIAGEN N.V
9. Thermo Fisher Scientific Inc.
10. Abbott